Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Silk ME"'
Autor:
Paulo César Ferreira Linhares, Maria Francisca Soares Pereira, Silk Meire da Silva Almeida, Antonia Edivanilde Soares da Paz, Anna Catarina Costa Paiva
Publikováno v:
Revista Verde de Agroecologia e Desenvolvimento Sustentável, Vol 6, Iss 1 (2011)
O experimento foi conduzido na casa de vegetação do Departamento de Ciências Vegetais da Universidade Federal Rural do Semi-Árido (UFERSA), Mossoró-RN, no período de outubro a novembro de 2008, com o objetivo de avaliar o efeito da adubação v
Externí odkaz:
https://doaj.org/article/247d42553ec84253994394a48d7a0b71
Autor:
Petri M; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: mpetri@jhmi.edu., Bruce IN; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, UK; National Institute for Health Research Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Dörner T; Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin, Berlin, Germany; Deutsches Rheumaforschungszentrum, Berlin, Germany., Tanaka Y; University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Morand EF; Centre for Inflammatory Disease, Monash University, Melbourne, VIC, Australia., Kalunian KC; Division of Rheumatology, University of California San Diego School of Medicine, La Jolla, CA, USA., Cardiel MH; Centro de Investigación Clínica de Morelia SC, Morelia, Michoacán, Mexico., Silk ME; Eli Lilly and Company, Indianapolis, IN, USA., Dickson CL; Eli Lilly and Company, Indianapolis, IN, USA., Meszaros G; Eli Lilly and Company, Indianapolis, IN, USA., Zhang L; Eli Lilly and Company, Indianapolis, IN, USA., Jia B; Eli Lilly and Company, Indianapolis, IN, USA., Zhao Y; Eli Lilly and Company, Indianapolis, IN, USA., McVeigh CJ; Eli Lilly and Company, Indianapolis, IN, USA., Mosca M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publikováno v:
Lancet (London, England) [Lancet] 2023 Mar 25; Vol. 401 (10381), pp. 1011-1019. Date of Electronic Publication: 2023 Feb 24.
Autor:
Morand EF; Centre for Inflammatory Disease, Monash University, Melbourne, VIC, Australia; School of Clinical Sciences, Monash University Clayton, Melbourne, VIC, Australia. Electronic address: eric.morand@monash.edu., Vital EM; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds, UK., Petri M; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., van Vollenhoven R; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands., Wallace DJ; Division of Rheumatology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, CA, USA., Mosca M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Furie RA; Division of Rheumatology, Northwell Health and Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA., Silk ME; Eli Lilly and Company, Indianapolis, IN, USA., Dickson CL; Eli Lilly and Company, Indianapolis, IN, USA., Meszaros G; Eli Lilly and Company, Indianapolis, IN, USA., Jia B; Eli Lilly and Company, Indianapolis, IN, USA., Crowe B; Eli Lilly and Company, Indianapolis, IN, USA., de la Torre I; Eli Lilly and Company, Indianapolis, IN, USA., Dörner T; Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin, Berlin, Germany; Deutsches Rheumaforschungszentrum, Berlin, Germany.
Publikováno v:
Lancet (London, England) [Lancet] 2023 Mar 25; Vol. 401 (10381), pp. 1001-1010. Date of Electronic Publication: 2023 Feb 24.
Autor:
Dörner T; Department Medicine/Rheumatology and Clinical Immunology, Charite - Universitätsmedizin Berlin and Deutsches Rheuma-Forschungszentrum (DRFZ), Chariteplatz, 01 10117, Berlin, Germany. thomas.doerner@charite.de., van Vollenhoven RF; University Medical Center, Amsterdam, The Netherlands., Doria A; University of Padova, Padova, Italy., Jia B; Eli Lilly and Company, Indianapolis, IN, USA., Ross Terres JA; Eli Lilly and Company, Indianapolis, IN, USA., Silk ME; Eli Lilly and Company, Indianapolis, IN, USA., de Bono S; Eli Lilly and Company, Indianapolis, IN, USA., Fischer P; Eli Lilly and Company, Indianapolis, IN, USA., Wallace DJ; Cedars-Sinai Medical Center and University of California at Los Angeles, Los Angeles, CA, USA.
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2022 May 16; Vol. 24 (1), pp. 112. Date of Electronic Publication: 2022 May 16.
Autor:
Birt JA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Hadi MA; Evidera, The Ark, 2nd floor, 201 Talgarth Road, London, UK. Monica.Hadi@evidera.com., Sargalo N; Evidera, The Ark, 2nd floor, 201 Talgarth Road, London, UK., Brookes E; Evidera, The Ark, 2nd floor, 201 Talgarth Road, London, UK., Swinburn P; Evidera, The Ark, 2nd floor, 201 Talgarth Road, London, UK., Hanrahan L; Lupus Foundation of America, Washington, DC, USA., Tse K; Lupus Foundation of America, Washington, DC, USA., Bello N; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Griffing K; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Silk ME; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Delbecque LA; Eli Lilly & Company, Brussels, Belgium., Kamen D; Medical University of South Carolina Health, Charleston, SC, USA., Askanase AD; Columbia University College of Physicians and Surgeons, New York, USA.
Publikováno v:
Rheumatology and therapy [Rheumatol Ther] 2021 Sep; Vol. 8 (3), pp. 1189-1205. Date of Electronic Publication: 2021 Jun 24.
Autor:
Dörner T; DRFZ Berlin and Department of Rheumatology and Clinical Immunology, Charite University Hospital Berlin, Berlin, Germany thomas.doerner@charite.de., Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health, Kitakyushu, Japan., Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Smolen JS; Division of Rheumatology, Medical University of Vienna, Wien, Austria., Wallace DJ; Department of Rheumatology, Cedars-Sinai Medical Center, West Hollywood, California, USA., Dow ER; Eli Lilly and Company, Indianapolis, Indiana, USA., Higgs RE; Eli Lilly and Company, Indianapolis, Indiana, USA., Rocha G; Eli Lilly and Company, Indianapolis, Indiana, USA., Crowe B; Eli Lilly and Company, Indianapolis, Indiana, USA., Benschop RJ; Eli Lilly and Company, Indianapolis, Indiana, USA., Byers NL; Eli Lilly and Company, Indianapolis, Indiana, USA., Silk ME; Eli Lilly and Company, Indianapolis, Indiana, USA., de Bono S; Eli Lilly and Company, Indianapolis, Indiana, USA., Fantini D; Eli Lilly and Company, Indianapolis, Indiana, USA., Hoffman RW; Eli Lilly and Company, Indianapolis, Indiana, USA.
Publikováno v:
Lupus science & medicine [Lupus Sci Med] 2020 Oct; Vol. 7 (1).
Autor:
Tuttle KR; Providence Health Care, Spokane, WA, USA.; The Kidney Research Institute, Division of Nephrology, University of Washington School of Medicine, Seattle, WA, USA.; The Institute of Translational Health Sciences, University of Washington School of Medicine, Seattle, WA, USA., Brosius FC 3rd; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Department of Internal Medicine, University of Arizona College of Medicine, Tucson, AZ, USA., Adler SG; Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA., Kretzler M; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Mehta RL; Division of Nephrology, University of California, San Diego, CA, USA., Tumlin JA; University of Tennessee College of Medicine, Chattanooga, TN, USA., Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Haneda M; Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan., Liu J; Eli Lilly and Company, Indianapolis, IN, USA., Silk ME; Eli Lilly and Company, Indianapolis, IN, USA., Cardillo TE; Eli Lilly and Company, Indianapolis, IN, USA., Duffin KL; Eli Lilly and Company, Indianapolis, IN, USA., Haas JV; Eli Lilly and Company, Indianapolis, IN, USA., Macias WL; Eli Lilly and Company, Indianapolis, IN, USA., Nunes FP; Eli Lilly and Company, Indianapolis, IN, USA., Janes JM; Eli Lilly and Company, Indianapolis, IN, USA.
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2018 Nov 01; Vol. 33 (11), pp. 1950-1959.
Autor:
Wallace DJ; Division of Rheumatology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, CA, USA. Electronic address: danielwallac@gmail.com., Furie RA; Division of Rheumatology, Zucker School of Medicine at Hofstra, Northwell, New York, NY, USA., Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Kalunian KC; Division of Rheumatology, University of California at San Diego School of Medicine, La Jolla, CA, USA., Mosca M; Division of Rheumatology, University of Pisa, Pisa, Italy., Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Dörner T; Division of Rheumatology, Charite Universitätsmedizin Berlin, Berlin, Germany., Cardiel MH; Centro de Investigación Clínica de Morelia SC, Morelia, México., Bruce IN; Arthritis Research UK Centre for Epidemiology, Faculty of Biology, Medicine and Health, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Gomez E; Eli Lilly and Company, Indianapolis, IN, USA., Carmack T; Eli Lilly and Company, Indianapolis, IN, USA., DeLozier AM; Eli Lilly and Company, Indianapolis, IN, USA., Janes JM; Eli Lilly and Company, Indianapolis, IN, USA., Linnik MD; Lilly Biotechnology Center, San Diego, CA, USA., de Bono S; Eli Lilly and Company, Indianapolis, IN, USA., Silk ME; Eli Lilly and Company, Indianapolis, IN, USA., Hoffman RW; Eli Lilly and Company, Indianapolis, IN, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2018 Jul 21; Vol. 392 (10143), pp. 222-231.
Autor:
Gallop K; Oxford Outcomes, an ICON plc company, Oxford, UK. katy.gallop@oxfordoutcomes.com, Nixon A, Swinburn P, Sterling KL, Naegeli AN, Silk ME
Publikováno v:
Lupus [Lupus] 2012 Aug; Vol. 21 (9), pp. 934-43. Date of Electronic Publication: 2012 Mar 20.